AU Patent

AU2018322769B2 — Daptomycin formulations

Assigned to Xellia Pharmaceuticals ApS · Expires 2021-12-02 · 4y expired

What this patent protects

The present invention relates to compositions comprising daptomycin and at least one amino acid, methods of providing such compositions and the uses thereof.

USPTO Abstract

The present invention relates to compositions comprising daptomycin and at least one amino acid, methods of providing such compositions and the uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018322769B2
Jurisdiction
AU
Classification
—
Expires
2021-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Xellia Pharmaceuticals ApS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.